Periprocedural Predictors of New-Onset Conduction Abnormalities After Transcatheter Aortic Valve Replacement

Kensuke Matsushita1,2, Mohamad Kanso1, Mickael Ohana3

  • 1Université de Strasbourg, Pôle d'Activité Médico-Chirurgicale Cardio-Vasculaire, Nouvel Hôpital Civil, Centre Hospitalier Universitaire.

Insights

New conduction abnormalities after TAVR increase mortality risk. Membranous septal length and implantation depth difference (∆MSID) predict these events, guiding future TAVR procedures.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Devices

Background:

  • New-onset conduction abnormalities (CAs) after transcatheter aortic valve replacement (TAVR) are linked to increased hospital readmissions and mortality.
  • Predictors for these CAs, including new-onset left bundle branch block (LBBB) and permanent pacemaker (PPM) implantation, are not well-established.

Purpose of the Study:

  • To identify clinical predictors of new-onset LBBB and new PPM implantation in patients undergoing TAVR.
  • To investigate the association between CAs and adverse clinical outcomes post-TAVR.

Main Methods:

  • A prospective registry enrolled 290 patients undergoing TAVR with SAPIEN 3 or Evolut R valves.
  • Computed tomography was used to assess membranous septal anatomy and implantation depth.
  • Multivariate analysis identified predictors of CAs and their association with clinical events.

Main Results:

  • Among 242 patients without pre-existing LBBB, 114 (47%) developed new-onset LBBB and/or required new PPM implantation.
  • A difference between membranous septal length and implantation depth (∆MSID) was the sole predictor for CAs with both valve types.
  • PR interval and ∆MSID were the only predictors in multivariate analysis. Patients with CAs had a significantly higher risk of adverse clinical events (HR: 2.10; P=0.004).

Conclusions:

  • Computed tomography assessment of membranous septal anatomy and implantation depth can predict CAs following TAVR with new-generation valves.
  • Further research is needed to determine if adjusting implantation depth can mitigate the risk of CAs and adverse outcomes.
Abstract

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
702
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
282
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
478
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
246
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
119
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
269